Your browser doesn't support javascript.
loading
[Retracted] miR­206 inhibits cancer initiating cells by targeting EHF in gastric cancer.
Gong, Yan-Cui; Ren, Guo-Liang; Liu, Bo; Li, Feng; Zhao, Hong-Peng; Chen, Jing-Bo; Li, Yu-Peng; Yu, Hai-Hua.
Afiliação
  • Gong YC; Health Management Center, Linyi Central Hospital, Linyi, Shandong 276400, P.R. China.
  • Ren GL; Intensive Care Unit (ICU), Dongying People's Hospital, Dongying, Shandong 257091, P.R. China.
  • Liu B; Department of Gastrointestinal Surgery, Shandong Provincial Qianfoshan Hospital, Jinan, Shandong 250014, P.R. China.
  • Li F; Department of Gastrointestinal Surgery, Shandong Provincial Qianfoshan Hospital, Jinan, Shandong 250014, P.R. China.
  • Zhao HP; Department of Gastrointestinal Surgery, Shandong Provincial Qianfoshan Hospital, Jinan, Shandong 250014, P.R. China.
  • Chen JB; Department of Gastrointestinal Surgery, Shandong Provincial Qianfoshan Hospital, Jinan, Shandong 250014, P.R. China.
  • Li YP; Department of Gastrointestinal Surgery, Shandong Provincial Qianfoshan Hospital, Jinan, Shandong 250014, P.R. China.
  • Yu HH; Department of Gastrointestinal Surgery, Shandong Provincial Qianfoshan Hospital, Jinan, Shandong 250014, P.R. China.
Oncol Rep ; 50(5)2023 Nov.
Article em En | MEDLINE | ID: mdl-37772393
ABSTRACT
Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that the colony formation assay data shown in Figs. 2, 4 and 8 were strikingly similar to data that had already appeared in another article written by different authors at different research institutes [Chen W, Wang J, Liu S, Wang S, Cheng Y, Zhou W, Duan C and Zhang C MicroRNA­361­3p suppresses tumor cell proliferation and metastasis by directly targeting SH2B1 in NSCLC. J Exp Clin Cancer Res 35 76, 732516, 2016]. Owing to the fact that the contentious data in the above article had already been published prior to its submission to Oncology Reports, the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused. [Oncology Reports 38 1688­1694, 2017; DOI 10.3892/or.2017.5794].
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Oncol Rep Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Oncol Rep Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article